Characterization of an early dendritic cell precursor derived from murine lineage-negative hematopoietic progenitor cells

Exp Hematol. 2002 May;30(5):430-9. doi: 10.1016/s0301-472x(02)00792-0.

Abstract

Objective: We define characteristics of a dendritic cell (DC) precursor generated from murine lineage-negative (Lin(-)) Sca1(+) hematopoietic progenitor cells (HPC).

Materials and methods: Lin(-)Sca1(+) HPC cultured 9 days in 100 ng/mL stem cell factor (SCF), 20 ng/mL interleukin-3 (IL-3), 50 ng/mL monocyte colony-stimulating factor (M-CSF), 5 ng/mL granulocyte-monocyte colony-stimulating factor (GM-CSF), and 25 ng/mL FLT3-ligand (FLT3-L) proliferate 387-fold and differentiate into DC precursors. Switch to > or =100 ng/mL GM-CSF + 1500 U/mL IL-4 or 500 U/mL tumor necrosis factor-alpha (TNF-alpha) for 3 days induces development into immature DC that are responsive to bacterial lipopolysaccharide (LPS)-induced maturation.

Results: Lin(-)Sca1(+) HPC in the first 9 days of culture differentiate into DC precursors expressing surface CD11b(bright), CD11c(mod), CD86(low-mod), major histocompatibility class II antigen (MHC) II(low), DEC 205(low), but are surface CD40(-) and contain high levels of intracellular MHC II. Unlike immature DC described by others, these DC precursors are refractory to maturation with LPS and minimally stimulate allogeneic T lymphocytes in mixed leukocyte reactions (MLR). Switch to high-dose GM-CSF alone with IL-4 or TNF-alpha differentiates these DC precursors into immature DC. LPS treatment of the immature DC results in mature DC that express surface CD40(high) and CD86(high), secrete IL-1beta and IL-12, and strongly stimulate MLR.

Conclusions: These studies define a distinct DC precursor derived from murine HPC that precedes development of immature and mature DC.

MeSH terms

  • Analysis of Variance
  • Animals
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cell Division / drug effects
  • Cells, Cultured
  • Dendritic Cells / cytology*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Hematopoietic Stem Cells / cytology*
  • Histocompatibility Antigens Class II / analysis
  • Interleukin-4 / pharmacology
  • Kinetics
  • Lymphocyte Culture Test, Mixed
  • Macrophage Colony-Stimulating Factor / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Stem Cell Factor / pharmacology
  • Time Factors

Substances

  • Histocompatibility Antigens Class II
  • Stem Cell Factor
  • Interleukin-4
  • Macrophage Colony-Stimulating Factor
  • Granulocyte-Macrophage Colony-Stimulating Factor